Wesbanco Bank Inc Novartis Ag Transaction History

Wesbanco Bank Inc

$2.64 Billion
Q2 2024

A detailed history of Wesbanco Bank Inc transactions in Novartis Ag stock. As of the latest transaction made, Wesbanco Bank Inc holds 4,099 shares of NVS stock, worth $466,343. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,099

Previous 4,544 9.79%

Holding current value

$466,343

Previous $439,000 0.68%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$92.57 - $107.37 $41,193 - $47,779	-445 Reduced 9.79%	4,099 $436,000
Q1 2024 Apr 23, 2024	BUY	$95.27 - $108.47 $62,116 - $70,722	652 Added 16.75%	4,544 $439,000
Q4 2023 Feb 16, 2024	SELL	$92.27 - $101.54 $68,372 - $75,241	-741 Reduced 15.99%	3,892 $392,000
Q2 2023 Jul 13, 2023	SELL	$92.52 - $104.91 $13,415 - $15,211	-145 Reduced 3.03%	4,633 $467,000
Q1 2023 Apr 21, 2023	SELL	$80.03 - $92.81 $18,086 - $20,975	-226 Reduced 4.52%	4,778 $439,000
Q4 2022 Jan 18, 2023	BUY	$75.55 - $92.52 $60,968 - $74,663	807 Added 19.23%	5,004 $454,000
Q3 2022 Oct 13, 2022	SELL	$74.61 - $87.26 $70,954 - $82,984	-951 Reduced 18.47%	4,197 $319,000
Q2 2022 Jul 18, 2022	SELL	$80.52 - $93.75 $21,418 - $24,937	-266 Reduced 4.91%	5,148 $435,000
Q4 2021 Feb 02, 2022	SELL	$79.7 - $88.13 $53,159 - $58,782	-667 Reduced 10.97%	5,414 $473,000
Q3 2021 Oct 12, 2021	SELL	$81.78 - $95.14 $58,554 - $68,120	-716 Reduced 10.53%	6,081 $497,000
Q2 2021 Aug 09, 2021	BUY	$85.24 - $94.15 $74,244 - $82,004	871 Added 14.7%	6,797 $620,000
Q1 2021 May 06, 2021	SELL	$83.5 - $98.47 $89,929 - $106,052	-1,077 Reduced 15.38%	5,926 $506,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $4,928 - $5,460	-60 Reduced 0.85%	7,003 $609,000
Q2 2020 Jul 14, 2020	SELL	$80.93 - $91.1 $5,260 - $5,921	-65 Reduced 0.91%	7,063 $616,000
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $34,628 - $48,514	-490 Reduced 6.43%	7,128 $588,000
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $5,482 - $6,199	-65 Reduced 0.85%	7,618 $722,000
Q3 2019 Nov 07, 2019	SELL	$85.54 - $94.26 $44,651 - $49,203	-522 Reduced 6.36%	7,683 $668,000
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $6,409 - $7,888	85 Added 1.05%	8,205 $749,000
Q1 2019 May 09, 2019	BUY	$75.32 - $86.15 $379,763 - $434,368	5,042 Added 163.81%	8,120 $780,000
Q4 2018 Feb 05, 2019	SELL	$73.66 - $82.02 $1,988 - $2,214	-27 Reduced 0.87%	3,078 $264,000
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $16,199 - $18,738	-242 Reduced 7.23%	3,105 $267,000
Q2 2018 Aug 08, 2018	BUY	$64.91 - $73.36 $42,386 - $47,904	653 Added 24.24%	3,347 $253,000
Q4 2017 Feb 01, 2018	SELL	$72.33 - $77.64 $4,484 - $4,813	-62 Reduced 2.25%	2,694 $227,000
Q3 2017 Nov 02, 2017	SELL	$74.14 - $77.27 $5,115 - $5,331	-69 Reduced 2.44%	2,756 $236,000
Q2 2017 Aug 08, 2017	BUY	N/A	2,825	2,825 $235,000

Others Institutions Holding NVS

# of Institutions

1,425

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $245B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Account

Wesbanco Bank Inc Novartis Ag Transaction History